upadacitinib
abbvie
['upadacitinib', 'ibd']
significantly higher rates of the co-primary induction endpoints were observed with upadacitinib than with placebo at week 12 #uegweek #gitwitter #ibd 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042